|Articles|May 2, 2004
In the Spotlight May 2004
Pharmaceutical science and technology innovations
Related Content
Trending on Pharmaceutical Technology
1
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
The Next Generation of Medicine: Personalized, Preventive, and Powered by Technology
4
What FDA's AI Warning Letter Tells Us About GMP Accountability
5